Literature DB >> 6491900

The deterministic identifiability of nonlinear pharmacokinetic models.

K R Godfrey, W R Fitch.   

Abstract

This paper deals with the deterministic identifiability of nonlinear pharmacokinetic models, namely, whether the model parameters can be identified with perfect data. It is shown that the most familiar method for analyzing the deterministic identifiability of linear models, in which the Laplace transform of the observation is examined, does not work for nonlinear models. An alternative method, in which the observation is expanded as a Taylor series about t = 0, is described and is illustrated with some examples of nonlinear models familiar in the pharmacokinetics literature, in which an elimination rate is assumed capacity limited, with Michaelis-Menten kinetics.

Mesh:

Substances:

Year:  1984        PMID: 6491900     DOI: 10.1007/bf01059277

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  13 in total

1.  The kinetics of alcohol elimination in man.

Authors:  F LUNDQUIST; H WOLTHERS
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1958

Review 2.  A modern view of pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

3.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

4.  Fasting and nonfasting blood ethanol concentrations following repeated oral administration of ethanol to one adult male subject.

Authors:  P K Wilkinson; A J Sedman; E Sakmar; Y J Lin; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

5.  Novel method of estimating volume of distribution of a drug obeying Michaelis-Menten elimination kinetics.

Authors:  Y J Lin; D J Weidler; D C Garg; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

6.  On the solution to the Michaelis-Menten equation.

Authors:  S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

7.  Identifiable pharmacokinetic models: the role of extra inputs and measurements.

Authors:  K R Godfrey; R P Jones; R F Brown
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

8.  Diphenylhydantoin elimination kinetics in overdosed children.

Authors:  L K Garrettson; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

9.  Nonlinear pharmacokinetics of the new positive inotropic agent sulmazole in the dog.

Authors:  E R Garrett; W Roth
Journal:  J Pharm Sci       Date:  1983-02       Impact factor: 3.534

10.  Pharmacokinetics of sulfaethidole in the rat: nonlinear multicompartment solution.

Authors:  M Kekki; R J Julkunen; H Pohjanpalo
Journal:  J Pharmacokinet Biopharm       Date:  1982-02
View more
  13 in total

1.  Nonlinearity detection: advantages of nonlinear mixed-effects modeling.

Authors:  E N Jonsson; J R Wade; M O Karlsson
Journal:  AAPS PharmSci       Date:  2000

2.  Optimal tumor targeting by antibodies: development of a mathematical model.

Authors:  M J Chappell; G D Thomas; K R Godfrey; A R Bradwell
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

3.  A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination.

Authors:  P Veng-Pedersen; J A Widness; J Wang; R L Schmidt
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

4.  Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models.

Authors:  Vijay K Siripuram; Daniel F B Wright; Murray L Barclay; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-06-13       Impact factor: 2.745

Review 5.  Identifiability and indistinguishability of nonlinear pharmacokinetic models.

Authors:  K R Godfrey; M J Chapman; S Vajda
Journal:  J Pharmacokinet Biopharm       Date:  1994-06

6.  On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.

Authors:  K R Godfrey; W R Fitch
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

Review 7.  Clinical pharmacokinetics of ethanol.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

8.  Statistical identifiability and convergence evaluation for nonlinear pharmacokinetic models with particle swarm optimization.

Authors:  Seongho Kim; Lang Li
Journal:  Comput Methods Programs Biomed       Date:  2013-10-22       Impact factor: 5.428

9.  Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.

Authors:  Jing Li; Seongho Kim; Anthony F Shields; Kirk A Douglas; Christopher I McHugh; Jawana M Lawhorn-Crews; Jianmei Wu; Thomas J Mangner; Patricia M LoRusso
Journal:  J Clin Pharmacol       Date:  2016-11       Impact factor: 3.126

10.  Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin.

Authors:  Andrés Olivares-Morales; Avijit Ghosh; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-09-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.